SAN DIEGO, June 1, 2015 /PRNewswire/ -- Diomics, an innovator in DNA capture technology, today announced that Richard M. Weissman, global financial executive, has joined Diomics' board of directors, effective immediately.
Mr. Weissman has more than 25 years of industry experience in broad global financial investment banking. Prior to Diomics, he served as a managing director at Credit Suisse and JP Morgan, and held executive positions at UBS and Morgan Stanley/Dean Witter.
"Diomics is on the forefront of innovation," said Mr. Weissman. "Diomat™ technology, with its ability to capture and release DNA from even the most scant samples, promises to revolutionize forensics and diagnostics. I'm excited to contribute to Diomics as it develops tools for these very important applications."
"We are thrilled to welcome Mr. Weissman to our board of directors," said Mr. John Steel, CEO of Diomics. "He brings a proven track record in guiding companies to commercial success. His global financial expertise will greatly benefit Diomics as we expand and grow the business."
Mr. Weissman graduated from Dartmouth College with a BA in economics/government, where he was captain of the varsity football team. He served as President of Dartmouth Football Alumni Association from 1997-2009, and board member of various other entities at the College and businesses.
About Diomics, Inc.
Diomics is focused on life sciences, specifically diagnostics, forensics, integrated DNA analysis, and genetic solutions. Our proprietary Diomat™ technology platform has the ability to efficiently pick up biologic materials from a variety of surfaces and release the majority of the DNA from the sample into the solution. The versatile characteristics of Diomat™ make it applicable to a variety of product formats, including swabs, films, and fibers. Today based in San Diego, California, Diomics has developed numerous products, tools, and services for the molecular diagnostic and forensic industries.
SOURCE Diomics, Inc.